ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers 2017
Aiming to provide the community of clinical oncologists specialising in adult solid tumours with a regular update of recent advances
- Date: 20 Jan 2017
Rare cancers make up as many as one fifth of all new cancer cases. Paediatric cancers and rare haematological neoplasms are often covered by dedicated educational events while rare adult solid cancers are hardly grouped together as a collective group of neoplasms. This ESO-ESMO-RCE joint event is aimed at dealing with them on an annual basis, to provide the community of clinical oncologists specialising in these tumours with a regular update of recent advances in this specific area. The ultimate goal is to strengthen the educational coverage of a group of cancers which may be neglected in spite of their collective incidence.
Any educational effort in the rare cancer area makes little sense if disconnected from a networking environment. Thus, this course will be first offered to clinical oncologists involved in existing networks covering adult solid rare cancers, with a special attention to European Reference Networks due to be created within the EU. Moreover, it will be part of the educational programme of the University of Milan's European Postgraduate Master Course on Rare Adult Solid Cancers, organised in collaboration with ESO.
Updates on the latest clinical development on rare cancers with a background perspective on the state-of-the-art approach
- Rare skin cancers and non-cutaneous melanoma
- Rare thoracic tumors
- Rare female genital cancers
- Neuroendocrine tumors
- Endocrine gland tumors
- Digestive rare cancers
- Rare urological and male genital tumors
- Central nervous system neoplasms
- Head and neck cancers
More information is to follow shortly.
European School of Oncology
Rare Tumours Programme
c/o Fondazione IRCCS Istituto Nazionale dei Tumori
Via G. Venezian, 1
20133 Milano - Italy